Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection

Journal of Nutrition

Volumn 136, Issue 11, 2006, Pages 2868-2873

  Ritz, Barry W ^a   Nogusa, Shoko ^a   Ackerman, Elizabeth A ^a   Gardner, Elizabeth M ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE HEXOSE CORRELATED COMPOUND; HEXOSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN INFLUENZA; BODY WEIGHT; CELL ACTIVITY; CELL SURVIVAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN;

AVES; BACTERIA (MICROORGANISMS); BASIDIOMYCOTA;

EID: 33751095144     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.11.2868     Document Type: Article

References (32)

1. Advisory Committee on Immunization Practices. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 2005;54(MM713).
2. th ed. New York, NY: WH Freeman, 2003.
3. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol. 2001;13:458-64.
4. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine. 2000;18:1613-20.
5. Neff-LaFord HD, Vorderstrasse BA, Lawrence BP. Fewer CTL, not enhanced NK cells, are sufficient for viral clearance from the lungs of immunocompromised mice. Cell Immunol. 2003;226:54-64.
6. Plett PA, Gardner EM, Murasko DM. Age-related changes in interferonalpha/beta receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice. Mech Ageing Dev. 2000;118:129-44.
7. Gardner EM. Caloric restriction decreases survival of aged mice in response to primary influenza infection. J Gerontol A Biol Sci Med Sci. 2005;60A:688-94.
8. Hunzeker J, Padgett DA, Sheridan PA, Dhabhar FS, Sheridan JF. Modulation of natural killer cell activity by restraint stress during an influenza A/PR8 infection in mice. Brain Behav Immun. 2004;18:526-35.
9. Tamura S, Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis. 2004;57:236-47.
10. Aviles H, Belay T, Vance M, Sun B, Sonnenfeld G. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol. 2004;97:1437-44.
11. Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li YQ, Hosokawa M. Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs. 1998;9:343-50.
12. Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki S. Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in rat. Endocr Regul. 2000;34:181-8.
13. Wang S, Wakame K, Igarashi Y, Kosuna K, Matsuzaki S. Beneficial effects of active hexose correlated compound (AHCC) on immobilization stress in rat. Dokkyo J Med Sci. 2001;28:559-65.
14. Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol Immunother. 2005;55:1258-66.
15. Matsui Y, Uhara J, Satoi S, Kaibori M, Yamada H, Kitade H, Imamura A, Takai S, Kawaguchi Y, et al. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study. J Hepatol. 2002;37:78-86.
16. Ghoneum M, Wimbley M, Salem F, McKlain A, Attallah N, Gill G. Immunomodulatory and anticancer effects of active hexose correlated compound (AHCC). Int J Immunother. 1995;11:23-8.
17. Ye SF, Ichimura K, Wakame K, Ohe M. Suppressive effects of active hexose correlated compound on the increased activity of hepatic and renal ornithine decarboxylase induced by oxidative stress. Life Sci. 2003;74:593-602.
18. Wang S, Ichimura K, Wakame K. Preventive effects of active hexose correlated compound (AHCC) on oxidative stress induced by ferric nitrilotriacetate in the rat. Dokkyo J Med Sci. 2001;28:745-52.
19. Po JL, Gardner EM, Anaraki F, Katsikis PD, Murasko DM. Age-associated decrease in virus-specific CD81 T lymphocytes during primary influenza infection. Mech Ageing Dev. 2002;123:1167-81.
20. Bender BS, Taylor SF, Zander DS, Cottey R. Pulmonary immune response of young and aged mice after influenza challenge. J Lab Clin Med. 1995;126:169-77.
21. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol. 2002;169:4279-87.
22. Bender BS, Johnson MP, Small PA. Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Immunology. 1991;72:514-9.
23. Moskophidis D, Kioussus D. Contribution of virus-specific CD81 cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med. 1998;188:223-32.
24. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet Microbiol. 2000;74:109-16.
25. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Saraneva T, Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine. 2001;19:S32-7.
26. Brydon EWA, Morris SJ, Sweet C. Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol Rev. 2005;29:837-50.
27. Liu B, Mori I, Hossain MJ, Dong L, Takeda K, Kimura Y. Interleuikin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol. 2004;85:423-8.
28. Yagita A, Matsuzaki S, Wakasugi S, Sukegawa Y. H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts. In Vivo. 2002;16:49-54.
29. Ghoneum M, Torabi M, Gill G, Wojdani A. Active hemicellulose compound (AHCC) enhances NK cell activity of aged mice in vivo [abstract]. FASEB J. 6:A1213.
30. Murasko DM, Gardner EM. Immunology of aging. In: Hazzard WR, Blass JP, Halter JB, Ouslander JG, Tinetti ME, editors. Principles of Geriatric Medicine & Gerontology, 5th ed. New York: McGraw-Hill, 2003;35-52.
31. Murasko DM, Jiang J. Resposne of aged mice to primary virus infections. Immunol Rev. 2005;205:285-96.
32. Gardner EM, Bernstein ED, Dran S, Munk G, Abrutyn E, Murasko DM. Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine. 2001;19:4610-7.